IRIS
CALABRO', Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.583
AS - Asia 11.731
NA - Nord America 11.655
SA - Sud America 1.929
AF - Africa 183
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 12
Totale 51.107
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 17.773
US - Stati Uniti d'America 11.454
SG - Singapore 4.403
IE - Irlanda 2.471
CN - Cina 2.412
HK - Hong Kong 1.760
BR - Brasile 1.632
VN - Vietnam 1.586
IT - Italia 1.002
GB - Regno Unito 961
UA - Ucraina 885
DE - Germania 811
KR - Corea 443
FR - Francia 436
IN - India 363
FI - Finlandia 331
SE - Svezia 310
GR - Grecia 223
TR - Turchia 217
AR - Argentina 128
JP - Giappone 113
AT - Austria 100
MX - Messico 84
CA - Canada 80
BD - Bangladesh 75
ID - Indonesia 65
PL - Polonia 50
BE - Belgio 49
ZA - Sudafrica 48
IQ - Iraq 47
NL - Olanda 47
EC - Ecuador 46
PK - Pakistan 45
MA - Marocco 38
CO - Colombia 30
ES - Italia 30
EG - Egitto 29
VE - Venezuela 24
KE - Kenya 22
UZ - Uzbekistan 22
CL - Cile 21
LT - Lituania 20
SA - Arabia Saudita 19
UY - Uruguay 17
JO - Giordania 16
NP - Nepal 15
PE - Perù 15
TH - Thailandia 15
TN - Tunisia 15
AE - Emirati Arabi Uniti 14
IL - Israele 14
PY - Paraguay 14
EU - Europa 12
IR - Iran 11
CH - Svizzera 10
PH - Filippine 10
CZ - Repubblica Ceca 9
AL - Albania 8
CR - Costa Rica 8
MY - Malesia 8
RS - Serbia 8
AU - Australia 7
AZ - Azerbaigian 7
KZ - Kazakistan 7
OM - Oman 7
RO - Romania 7
TW - Taiwan 7
DK - Danimarca 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
DZ - Algeria 5
NO - Norvegia 5
PA - Panama 5
PT - Portogallo 5
AM - Armenia 4
BG - Bulgaria 4
EE - Estonia 4
ET - Etiopia 4
HN - Honduras 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
CI - Costa d'Avorio 3
GA - Gabon 3
GT - Guatemala 3
KG - Kirghizistan 3
MD - Moldavia 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
BN - Brunei Darussalam 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
GE - Georgia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LU - Lussemburgo 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
Totale 51.077
Salva come PNG Salva come JPEG
Città #
Moscow 6.476
Dublin 2.454
Santa Clara 1.902
Singapore 1.829
Hong Kong 1.734
San Jose 1.622
Jacksonville 1.377
Chandler 1.101
Ashburn 568
Ho Chi Minh City 527
Hefei 505
Seoul 428
Hanoi 371
Princeton 362
Beijing 283
Roxbury 276
Medford 241
Bengaluru 225
New York 214
The Dalles 213
Boardman 199
Naples 170
Wilmington 145
Bremen 138
Cambridge 132
Houston 128
Dallas 125
Ann Arbor 124
Da Nang 123
São Paulo 123
Nuremberg 111
Woodbridge 106
San Mateo 105
Helsinki 90
Los Angeles 88
Des Moines 85
Council Bluffs 61
Nanjing 61
Haiphong 58
Munich 58
Rio de Janeiro 57
Milan 55
Falkenstein 53
Mountain View 49
Düsseldorf 48
Orem 47
Brussels 45
Belo Horizonte 38
Norwalk 37
Vienna 37
Curitiba 35
Guangzhou 35
Frankfurt am Main 34
Rome 34
Tokyo 34
Caserta 32
Aversa 31
Biên Hòa 31
Brasília 30
Brooklyn 29
Chennai 28
Mexico City 28
Jinan 27
Hải Dương 26
London 26
Johannesburg 25
Turku 25
Amsterdam 24
Atlanta 24
Porto Alegre 24
Shanghai 24
Hyderabad 23
Thái Nguyên 23
Boston 22
Campinas 22
Ercolano 22
Lappeenranta 22
Warsaw 22
Ninh Bình 21
Thái Bình 21
Tianjin 21
Columbus 20
Nanchang 20
Salvador 20
Istanbul 19
Nairobi 19
Philadelphia 19
Tashkent 19
Baghdad 18
Bắc Ninh 18
Bến Tre 18
Changsha 18
Chicago 18
Hangzhou 18
Napoli 18
Nha Trang 18
Shenyang 18
Can Tho 17
Montreal 17
San Francisco 17
Totale 26.578
Salva come PNG Salva come JPEG
Nome #
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 234
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 215
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 185
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 180
A simple method for the isolation, cultivation, and characterization of endothelial cells from rabbit coronary circulation 180
Adherence to proprotein convertase subtilisin/kexin 9 inhibitors in high cardiovascular risk patients: an Italian single-center experience 180
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation 178
Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy? 177
Advanced Heart Failure in Special Population—Pediatric Age 174
. Accuratezza predittiva dell'elettrocardiogramma nell'identificazione dell'ipertrofia ventricolare sinistra. 166
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 166
Adipose tissue and vascular inflammation in coronary artery disease. 165
Activated coagulation factor VII promotes smooth muscle cell proliferation in vitro. 165
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 162
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 162
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 161
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 159
A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy 158
Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. 157
Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and 'narrow' QRS 157
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 156
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: Results from a multicenter Italian experience. 155
Lomitapide in homozygous familial hypercholesterolemia: cardiology perspective from a single-center experience 155
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 155
A new character on the scene of cardiorenal syndrome 152
Adherence to PCSK9 inhibitors in high cardiovascular risk patients in real-world setting: results from a single-center experience and comparison with statin therapy 152
Antithrombotic therapy in patients with atrial high-rate episodes (AHREs): Current evidence and open questions 151
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 151
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 150
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 150
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 149
Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? 149
Natural history of left ventricular hypertrophy in infants of diabetic mothers 149
Association between left atrial myocardial function and exercise capacity in patients with either idiophatic or ischemic dilated cardiomyopathy: a two-dimensional speckle strain study 148
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery Surgery After Stenting 2 148
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 148
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia 148
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 147
. Left atrial strain/strain rate analylisis in patients with dilated cardiomyopathy. Correlation with clinical, electrocardiographic and echocardiographic findings 146
Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study) 145
Childhood obesity: An overview of laboratory medicine, exercise and microbiome 145
[Device therapy in chronic heart failure: a case of hypertrophic cardiomyopathy treated with cardiac contractility modulation therapy] 144
Cardiotrophin-1 and TNF-alpha circulating levels at rest and during cardiopulmonary exercise test in athletes and healthy individuals 144
. Plasma CT1 analysis in patients with hypertrophic cardiomyopathy. 144
Antiplatelet therapy for non-ST-Segment elevation myocardial infarction in complex "real" Clinical Scenarios: A Consensus Document of the "campania NSTEMI Study Group" 144
[The COMPASS study] 144
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: The T.O.S.CA. Registry 144
. L’analisi DMI del ventricolo destro a riposo predice la performance all’apice dello sforzo dei pazienti adulti operati per tetralogia di Fallot 142
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: the emerging role of the Cardiomyopathy Team 142
. Ultrasonic myocardial tissue characterization in normal and abnormal right ventricle 141
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 141
.: Correlations between right ventricular myocardial function and cardiac performance during exercise in adult patients late after repair of tetralogy of Fallot 140
Activated platelets stimulate tissue factor expression in smooth muscle cells 139
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 139
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 138
Nuove prospettive nella terapia dello scompenso cardiaco: Farmacogenetica, Farmacogenomica e terapia cellulare. 137
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 137
Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy: A Contemporary Perspective 136
Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 136
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A contemporary reappraisal 136
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 136
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry) 134
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries 133
Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation 133
. Integrated backscatter analysis of functional and textural findings in young patients with different pathophysiological models of right ventricular overload 132
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target 131
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 131
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 130
Feasibility and usefulness of right ventricular ultrasonic tissue characterization with integrated backscatter in patients with unsuccessfully operatively "repaired" tetralogy of Fallot 130
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 130
ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor 129
Impact of GEne Polymorphisms, Platelet REactivity and the SYNTAX Score on 1-Year Clinical Outcomes in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The GEPRESS Study. 129
Obesità in età pediatrica ed ipertensione arteriosa 129
Registrazione del potenziale di azione monofasico e del recupero ventricolare a seguito di variazioni acute del sovraccarico di volume: evidenza in vivo del feedback elettromeccanico 129
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 129
New frontiers in antiplatelet therapy: guided therapy and de-escalation after acute coronary syndrome or percutaneous coronary intervention 127
Reduction of new onset of atrial fibrillation in patients treated with semaglutide: an updated systematic review and meta regression analysis of randomized controlled trials 127
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 127
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 127
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy 127
[Evaluation and percutaneous treatment of severely calcified coronary lesions] 127
[Debate on antiplatelet monotherapy: P2Y12 inhibitor monotherapy in patients with coronary artery disease] 126
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 126
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 126
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 125
Induction of tissue factor in the arterial wall during recurrent thrombus formation 125
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 125
Effect of body mass index reduction on serum hepcidin levels and iron status in obese children 124
Coronary Physiology Assessment for the Diagnosis and Treatment of Coronary Artery Disease 124
Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy 123
The left atrial appendage: from embryology to prevention of thromboembolism 123
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 123
A Prospective Study to Evaluate the Effectiveness of Edoxaban for the Resolution of Left Atrial Thrombosis in Patients with Atrial Fibrillation 123
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go 122
Role of LipoprotEin(a) in CardiovascuLar diseases and premature acute coronary syndromes (RELACS study): Impact of Lipoprotein(a) levels on the premature coronary event and the severity of coronary artery disease 122
Anti-inflammatory therapies for cardiovascular diseases: novel evidence, clinical implications, and future perspectives 122
Update of the position document of the Italian Society of Interventional Cardiology (SICI-GISE) on the minimum requirements for hospitals and operators performing procedures of a transcatheter implantation of aortic valve prostheses 122
Cardiac involvement in systemic sclerosis: 'early diagnosis-early management' approach 122
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study 122
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 122
Totale 14.372
Salva come PNG Salva come JPEG
Categoria #
all - tutte 171.760
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 171.760
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021612 0 0 0 0 0 0 0 0 0 244 285 83
2021/20222.391 130 13 26 82 785 27 36 148 86 184 147 727
2022/20234.257 452 145 58 348 401 307 10 206 2.136 32 78 84
2023/20242.109 144 59 76 161 680 223 86 74 12 57 155 382
2024/20257.551 26 74 35 213 1.164 1.071 1.092 614 956 1.186 644 476
2025/202630.339 1.110 1.504 1.635 1.545 2.349 16.660 1.920 1.546 1.220 850 0 0
Totale 52.096